Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Support Provided By
57:46
Israel's Prime Minister says the intense phase of the war in Gaza will end soon as Israel and the U.S. argue over weapons deliveries.
57:46
After Claudia Sheinbaum becomes the first woman to win Mexico's presidential election, a look at what that means for U.S. relations.
26:44
"PBS NewsHour" asks NATO’s Secretary General if the delayed U.S. aid to Ukraine is too late to make a difference.
56:45
A court rejects Trump's claim of immunity with major implications for his election interference case.
26:36
Why a record number of people across America are experiencing homelessness this holiday season.
24:44
How some cities are testing no-strings-attached payment programs as a way to help lower-income residents get a leg up.
56:45
Hunter Biden's plea deal unravels over concerns about whether future charges can be brought against the president's son.
56:45
Floodwaters rage and dangerous heat waves grow worse, posing serious risks to millions of Americans.
56:44
NATO leaders kick off a multi-nation summit with Ukraine seeking a path to join the expanding alliance.